Benefit of 5 years of enzyme replacement therapy in advanced late onset Pompe. A case report of misdiagnosis for three decades with acute respiratory failure at presentation

We report on a 57 year old female patient who presented in acute respiratory failure with severe generalized weakness. She was previously misdiagnosed for over three decades as polymyositis. She was treated with enzyme replacement therapy (ERT) for over five years, after being diagnosed with late on...

Full description

Bibliographic Details
Main Authors: Mandat Maharaj, David L. Skidmore, Sidney E. Croul, David J. Brake, Hanns Lochmuller
Format: Article
Language:English
Published: Elsevier 2022-09-01
Series:Molecular Genetics and Metabolism Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2214426922000568
_version_ 1798042329376882688
author Mandat Maharaj
David L. Skidmore
Sidney E. Croul
David J. Brake
Hanns Lochmuller
author_facet Mandat Maharaj
David L. Skidmore
Sidney E. Croul
David J. Brake
Hanns Lochmuller
author_sort Mandat Maharaj
collection DOAJ
description We report on a 57 year old female patient who presented in acute respiratory failure with severe generalized weakness. She was previously misdiagnosed for over three decades as polymyositis. She was treated with enzyme replacement therapy (ERT) for over five years, after being diagnosed with late onset Pompe Disease (LOPD). She returned to independent living with the use of non invasive ventilation at nights. ERT should be considered in the management of patients with advanced LOPD and the effects of ERT closely monitored.
first_indexed 2024-04-11T22:34:03Z
format Article
id doaj.art-95dc199ff5cd4fc2856b0b911be0db21
institution Directory Open Access Journal
issn 2214-4269
language English
last_indexed 2024-04-11T22:34:03Z
publishDate 2022-09-01
publisher Elsevier
record_format Article
series Molecular Genetics and Metabolism Reports
spelling doaj.art-95dc199ff5cd4fc2856b0b911be0db212022-12-22T03:59:16ZengElsevierMolecular Genetics and Metabolism Reports2214-42692022-09-0132100896Benefit of 5 years of enzyme replacement therapy in advanced late onset Pompe. A case report of misdiagnosis for three decades with acute respiratory failure at presentationMandat Maharaj0David L. Skidmore1Sidney E. Croul2David J. Brake3Hanns Lochmuller4Cape Breton Regional Hospital, Cape Breton, Nova Scotia, Dalhousie University, Canada; Corresponding author.IWK Hospital, Halifax, Nova Scotia, Dalhousie University, CanadaQueen Elizabeth Hospital, Halifax, Nova Scotia, Dalhousie University, CanadaCape Breton Regional Hospital, Cape Breton, Nova Scotia, Dalhousie University, CanadaThe Ottawa Hospital, Ottawa, Ontario, The University of Ottawa, CanadaWe report on a 57 year old female patient who presented in acute respiratory failure with severe generalized weakness. She was previously misdiagnosed for over three decades as polymyositis. She was treated with enzyme replacement therapy (ERT) for over five years, after being diagnosed with late onset Pompe Disease (LOPD). She returned to independent living with the use of non invasive ventilation at nights. ERT should be considered in the management of patients with advanced LOPD and the effects of ERT closely monitored.http://www.sciencedirect.com/science/article/pii/S2214426922000568Late onset Pompe diseaseMisdiagnosisEnzyme replacement therapyAlglucosidase alfa
spellingShingle Mandat Maharaj
David L. Skidmore
Sidney E. Croul
David J. Brake
Hanns Lochmuller
Benefit of 5 years of enzyme replacement therapy in advanced late onset Pompe. A case report of misdiagnosis for three decades with acute respiratory failure at presentation
Molecular Genetics and Metabolism Reports
Late onset Pompe disease
Misdiagnosis
Enzyme replacement therapy
Alglucosidase alfa
title Benefit of 5 years of enzyme replacement therapy in advanced late onset Pompe. A case report of misdiagnosis for three decades with acute respiratory failure at presentation
title_full Benefit of 5 years of enzyme replacement therapy in advanced late onset Pompe. A case report of misdiagnosis for three decades with acute respiratory failure at presentation
title_fullStr Benefit of 5 years of enzyme replacement therapy in advanced late onset Pompe. A case report of misdiagnosis for three decades with acute respiratory failure at presentation
title_full_unstemmed Benefit of 5 years of enzyme replacement therapy in advanced late onset Pompe. A case report of misdiagnosis for three decades with acute respiratory failure at presentation
title_short Benefit of 5 years of enzyme replacement therapy in advanced late onset Pompe. A case report of misdiagnosis for three decades with acute respiratory failure at presentation
title_sort benefit of 5 years of enzyme replacement therapy in advanced late onset pompe a case report of misdiagnosis for three decades with acute respiratory failure at presentation
topic Late onset Pompe disease
Misdiagnosis
Enzyme replacement therapy
Alglucosidase alfa
url http://www.sciencedirect.com/science/article/pii/S2214426922000568
work_keys_str_mv AT mandatmaharaj benefitof5yearsofenzymereplacementtherapyinadvancedlateonsetpompeacasereportofmisdiagnosisforthreedecadeswithacuterespiratoryfailureatpresentation
AT davidlskidmore benefitof5yearsofenzymereplacementtherapyinadvancedlateonsetpompeacasereportofmisdiagnosisforthreedecadeswithacuterespiratoryfailureatpresentation
AT sidneyecroul benefitof5yearsofenzymereplacementtherapyinadvancedlateonsetpompeacasereportofmisdiagnosisforthreedecadeswithacuterespiratoryfailureatpresentation
AT davidjbrake benefitof5yearsofenzymereplacementtherapyinadvancedlateonsetpompeacasereportofmisdiagnosisforthreedecadeswithacuterespiratoryfailureatpresentation
AT hannslochmuller benefitof5yearsofenzymereplacementtherapyinadvancedlateonsetpompeacasereportofmisdiagnosisforthreedecadeswithacuterespiratoryfailureatpresentation